1. In Vitro Inhibitory Effect of Recombinant Human Calprotectin on Nalm6 Leukemia Cell Line
    Samira Charkhizadeh et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  2. Calprotectin in viral systemic infections—COVID-19 versus hepatitis C virus
    Letitia Toma et al, 2022, Clinical and Experimental Medicine CrossRef
  3. Non-IgE-Mediated Gastrointestinal Food Protein-Induced Allergic Disorders. Clinical Perspectives and Analytical Approaches
    Elisa Zubeldia-Varela et al, 2021, Foods CrossRef
  4. Faecal calprotectin as an aid to the diagnosis of non-IgE mediated cow's milk protein allergy
    Carlos Trillo Belizón et al, 2016, Anales de Pediatría (English Edition) CrossRef
  5. Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
    Ying Cao et al, 2021, Journal of Inflammation Research CrossRef
  6. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
    Jia-Feng Wu et al, 2024, Intestinal Research CrossRef
  7. Second Mexican consensus on biologic therapy and small-molecule inhibitors in inflammatory bowel disease
    J.K. Yamamoto-Furusho et al, 2021, Revista de Gastroenterología de México (English Edition) CrossRef
  8. Non–IgE- or Mixed IgE/Non–IgE-Mediated Gastrointestinal Food Allergies in the First Years of Life: Old and New Tools for Diagnosis
    Mauro Calvani et al, 2021, Nutrients CrossRef
  9. Evaluating the Potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A Pilot Study
    Yunyao Qu et al, 2023, Nutrients CrossRef
  10. Management of Irritable Bowel Syndrome in the Patient with Ulcerative Colitis
    Philip M. Ginsburg et al, 2014, Medical Therapy of Ulcerative Colitis CrossRef
  11. Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
    Shu Chen Wei, 2016, Intestinal Research CrossRef
  12. A new uses of calprotectin as an inflammation biomarker
    Agnieszka Wierzbicka et al, 2023, Diagnostyka Laboratoryjna CrossRef
  13. High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease
    Jee-Yon Lee et al, 2020, Cell Host & Microbe CrossRef
  14. Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study
    Eslam Safwat et al, 2020, Arab Journal of Gastroenterology CrossRef
  15. Host intestinal biomarker identification in a gut leakage model in broilers
    Fien De Meyer et al, 2019, Veterinary Research CrossRef
  16. Optimal cut‐off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?
    Ashish Kumar Jha et al, 2018, JGH Open CrossRef
  17. ROLE OF FECAL CALPROTECTIN IN DIFFERENTIATION OF INFLAMMATORY BOWEL DISEASES IN PATIENTS COMPLAINING OF ABDOMINAL SYMPTOMS AND REFERRED FOR COLONOSCOPY
    Trifa Mahmood et al, 2021, JOURNAL OF SULAIMANI MEDICAL COLLEGE CrossRef
  18. Segundo Consenso Mexicano de terapia biológica y moléculas pequeñas en enfermedad inflamatoria intestinal
    J.K. Yamamoto-Furusho et al, 2021, Revista de Gastroenterología de México CrossRef
  19. Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review
    Abdulaziz S Asiri et al, 2023, Cureus CrossRef
  20. Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
    Ivana Plavšić et al, 2015, Gastroenterology Research and Practice CrossRef
  21. Recent advances in the diagnosis of irritable bowel syndrome
    Magdy El-Salhy, 2015, Expert Review of Gastroenterology & Hepatology CrossRef
  22. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Alonso Carrasco-Labra et al, 2019, Gastroenterology CrossRef
  23. Cows’ Milk Allergy-Associated Constipation: When to Look for It? A Narrative Review
    Frances Connor et al, 2022, Nutrients CrossRef
  24. Developments in pathophysiology, diagnosis and management
    Peter J. Whorwell, 2015, Nature Reviews Gastroenterology & Hepatology CrossRef
  25. Consenso mexicano sobre el síndrome de intestino irritable
    R. Carmona-Sánchez et al, 2016, Revista de Gastroenterología de México CrossRef
  26. The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome
    Yunyao Qu et al, 2023, Nutrients CrossRef
  27. Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases
    Raheleh Heydari et al, 2024, Inflammatory Bowel Diseases CrossRef
  28. Identifying the shortfalls of crude protein-reduced, wheat-based broiler diets
    Peter H. Selle et al, 2022, Animal Nutrition CrossRef
  29. Calprotectina fecal como apoyo al diagnóstico en la alergia a las proteínas de leche de vaca no IgE mediada
    Carlos Trillo Belizón et al, 2016, Anales de Pediatría CrossRef
  30. Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels
    Fernando Magro et al, 2019, Gut CrossRef
  31. Excluding irritable bowel syndrome in the inflammatory bowel disease patient
    Divyesh Reddy Nemakayala et al, 2019, Current Opinion in Gastroenterology CrossRef
  32. Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome
    Seok-Hoon Lee et al, 2019, The American Journal of the Medical Sciences CrossRef
  33. Calprotectin in inflammatory bowel disease
    Fatemeh Khaki-Khatibi et al, 2020, Clinica Chimica Acta CrossRef
  34. Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review
    Yueying Chen et al, 2022, eClinicalMedicine CrossRef
  35. Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease
    Erin Crawford et al, 2021, JPGN Reports CrossRef
  36. Irritable Bowel Syndrome: Diagnosis
    Marcin Włodarczyk et al, 2017, Introduction to Gastrointestinal Diseases Vol. 1 CrossRef
  37. Clinical Significance of Changes in Serum Biochemical Indices, Blood Routine and Coagulation Function in Patients with Inflammatory Bowel Disease
    阳丽 徐, 2024, Advances in Clinical Medicine CrossRef
  38. Systematic review with meta‐analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults
    Elton Dajti et al, 2023, Alimentary Pharmacology & Therapeutics CrossRef
  39. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis
    Caterina Carco et al, 2020, Frontiers in Cellular and Infection Microbiology CrossRef
  40. ACG Clinical Guideline: Management of Crohn's Disease in Adults
    Gary R Lichtenstein et al, 2018, American Journal of Gastroenterology CrossRef
  41. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
    Maria Gloria Mumolo et al, 2018, World Journal of Gastroenterology CrossRef
  42. A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity
    Joachim Høg Mortensen et al, 2022, Journal of Crohn's and Colitis CrossRef
  43. First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus
    Maryam Alkhatry et al, 2020, World Journal of Gastroenterology CrossRef
  44. Irritable bowel syndrome in China: a review on the epidemiology, diagnosis, and management
    Yi-Lin Liu et al, 2021, Chinese Medical Journal CrossRef
  45. The Mexican consensus on irritable bowel syndrome
    R. Carmona-Sánchez et al, 2016, Revista de Gastroenterología de México (English Edition) CrossRef
  46. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease
    Shapur Ikhtaire et al, 2016, Journal of Gastroenterology CrossRef
  47. The correlation between the concentration of faecal calprotectin and markers of inflammation in children with gastrointestinal disorders
    Katarzyna Lewandowska et al, 2017, Diagnostyka Laboratoryjna CrossRef
  48. Pediatric inflammatory bowel disease
    Akshay Kapoor et al, 2016, Indian Pediatrics CrossRef
  49. Fecal Calprotectin as an Intestinal Inflammation Marker is Elevated in Glaucoma
    Zuo Wang et al, 2023, Biomarkers in Medicine CrossRef
  50. Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID‐19
    Haoran Zhang et al, 2024, Immunity, Inflammation and Disease CrossRef